Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

183
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
183
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

358
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
358
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

64
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
64
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

131
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
131
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

131
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
131

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Multisite Real-World Validation of an Electronic Health Record-Integrated Generative Artificial Intelligence Tool for Venous Thromboembolism Risk Stratification.

medRxiv : the preprint server for health sciences·2026
Same author

An examination of the availability and characteristics of social needs data in the electronic health records: a path to social data harmonization and standardization at Johns Hopkins medicine.

JAMIA open·2026
Same author

Neuroretinal Layer Thinning on OCT Imaging and Hemoglobin A1c in Youth With Type 1 Diabetes.

JAMA ophthalmology·2026
Same author

Effects of Metabolic Dysregulation on Macrophage Polarization in Rheumatoid Arthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Beyond Missingness: Systematizing Methods for Comprehensive Data Fitness Assessment in Clinical Research.

Journal of medical Internet research·2026
Same author

The Potential Implications of Informatics for Value-Based Bare.

Journal of the American Medical Informatics Association : JAMIA·2026

相关实验视频

Updated: Jul 5, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

适用领域:一种新的基于实用性的方法,用于评估超越歧视的预测模型.

Star Liu1, Shixiong Wei1, Harold P Lehmann1

  • 1Johns Hopkins University School of Medicine, Baltimore, MD, United States.

AMIA ... Annual Symposium proceedings. AMIA Symposium
|January 15, 2024
PubMed
概括

我们介绍了适用性区域 (ApAr),这是评估医疗保健中的机器学习模型的新方法. ApAr证明了一个模型在各种患者群体中的临床实用性,提供比传统指标更全面的评估.

科学领域:

  • * 医学信息学 医学信息学
  • * 机器学习评估
  • *临床决策支持 *临床决策支持

背景情况:

  • * 评估临床实践的机器学习模型需要评估其超出歧视权的实际实用性.
  • *当前的方法往往侧重于像接收器操作特征曲线下的面积 (AUROC) 这样的指标,这些指标不能完全捕捉临床决策的复杂性.

研究的目的:

  • * 引入和评估适用性领域 (ApAr),一种新的决策分析,基于实用性的方法来评估预测模型的性能.
  • * 为了证明ApAr如何与现有指标相比,可以更全面地评估模型的临床价值.

主要方法:

  • *开发适用性区域 (ApAr) 度量,它量化了预先概率和测试截止值的范围,预测模型提供了积极的实用性.
  • *使用模拟数据集和三个已发表的医疗数据集验证ApAr.
  • * 将ApAr排名与传统的AUROC指标分析进行比较.

主要成果:

  • * ApAr指标在评估预测模型方面提供了额外的价值,补充了传统的AUROC分析.
  • * 在糖尿病数据集示例中,ApAr排名最高的模型在AUROC排名 (23位) 中排名明显较低,突出了模型评估的差异.
  • *较大的ApAr值表明预测模型的临床适用性范围更广.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Cross-Modal Multivariate Pattern Analysis
13:51

Cross-Modal Multivariate Pattern Analysis

Published on: November 9, 2011

20.0K

相关实验视频

Last Updated: Jul 5, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Cross-Modal Multivariate Pattern Analysis
13:51

Cross-Modal Multivariate Pattern Analysis

Published on: November 9, 2011

20.0K

结论:

  • *适用性领域 (ApAr) 为评估预测模型的临床价值提供了一个优越的,基于实用性的框架.
  • * ApAr帮助决策者确定模型的实用性是否与当地临床环境和患者群体保持一致.
  • *这种方法有助于在医疗保健环境中更明智地采用和实施机器学习模型.